PROJECT

Projects

Summary of Investment Information

Project Number

46979

Company Name

SANSURE BIOTECH INC.

Date SPI Disclosed

Apr 17, 2023

Country

China

Region

East Asia and the Pacific

Projected Board Date

Dec 14, 2022

Environmental Category

B - Limited

Status

Completed

Last Updated Date

May 21, 2025

Department

Regional Industry - MAS Asia & Pac

Industry

other

Previous Events

Approved : Dec 14, 2022
Signed : Apr 17, 2023
Invested : Jan 18, 2024

Sector

other

Project Description

 The proposed investment is an A loan to Sansure Biotech, Inc. (Sansure, or the Company), to support its (i) increase in production capacity of in-vitro diagnostics (IVD) products in China, and (ii) expand into Southeast Asia and Africa through the setting up of local operations (the Project).

Sponsor / Cost / Location

Development Impact

E&S Category Rationale / Risks and Mitigation